menu
    • menu

    Company profile for RxSight

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery. The company’s mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every unique eye.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RxSightUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Columbia, Aliso Viejo, CA 92656
    Telephone
    Telephone
    833.888.7974
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rxsight.com/us
    Linkedin
    Linkedin
    https://www.linkedin.com/company/calhoun-vision-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/RxSight

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rxsight To Release Q1 2026 Financial Results On May 6
    Rxsight To Release Q1 2026 Financial Results On May 6

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3279393/0/en/rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    RxSight Marks 300K Lens Implants at ASCRS 2026
    RxSight Marks 300K Lens Implants at ASCRS 2026

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270503/0/en/RxSight-Highlights-300-000-Light-Adjustable-Lens-Implant-Milestone-and-Strong-Scientific-Presence-at-ASCRS-2026.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    RxSight to Participate in Needham Annual Healthcare Conference
    RxSight to Participate in Needham Annual Healthcare Conference

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267837/0/en/RxSight-Inc-to-Participate-in-the-25th-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Rxsight Reports Q4 2025 Results; Guides For 2026
    Rxsight Reports Q4 2025 Results; Guides For 2026

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3245000/0/en/RXSight-Inc-Reports-Fourth-Quarter-and-2025-Results-Issues-2026-Guidance.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    RxSight to Report Q4, FY 2025 Earnings on Feb. 25, 2026
    RxSight to Report Q4, FY 2025 Earnings on Feb. 25, 2026

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236670/0/en/RxSight-Inc-To-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-25-2026.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Rxsight Reveals Q4 & 2025 Financials; Appoints Cfo
    Rxsight Reveals Q4 & 2025 Financials; Appoints Cfo

    11 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/11/3216471/0/en/RxSight-Inc-Announces-Preliminary-Q4-and-2025-Financial-Results-New-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    11 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search